XML 47 R7.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2020
Sep. 30, 2019
Mar. 31, 2019
Sep. 30, 2018
Mar. 31, 2020
Mar. 31, 2019
Jun. 30, 2019
Cash flows from operating activities:              
Net loss $ (2,068) $ (2,068) $ (1,394) $ (2,238) $ (6,219) $ (5,792)  
Adjustments to reconcile net loss to net cash used in operating activities:              
Stock-based compensation         282 205  
Depreciation and amortization         327 206  
Deferred income tax benefit         0 (429)  
Net loss on sale of available-for-sale investments         0 31  
Changes in assets and liabilities:              
Accounts receivable         (82) (29)  
Inventory         (262) 0  
Income tax receivable         0 (429)  
Accounts payable         28 27  
Other assets and liabilities         970 (340)  
Net cash used in operating activities         (4,956) (6,550) $ (8,500)
Cash flows from investing activities:              
Proceeds from sale of available-for-sale investments         0 3,345  
Proceeds from maturities of securities         0 250  
Sale of property and equipment         0 2  
Net cash provided by investing activities         0 3,597  
Cash flows from financing activities:              
Payments for purchase of treasury stock         0 (1)  
Proceeds from term note payable - related party         2,500 0  
Proceeds from exercise of stock options         0 7  
Proceeds from issuance of stock, net of offering issuance costs         5,650 3,919  
Net cash provided by financing activities         8,150 3,925  
Net change in cash and cash equivalents and restricted cash         3,194 972  
Cash and cash equivalents and restricted cash at beginning of period   1,588   $ 552 1,588 552 552
Cash and cash equivalents and restricted cash at end of period 4,782   1,524   4,782 1,524 1,588
Reconciliation of cash and cash equivalents and restricted cash at end of period:              
Cash and cash equivalents 4,660   1,524   4,660 1,524 $ 1,588
Restricted cash 122   0   122 0  
Total reconciliation of cash and cash equivalents and restricted cash at end of period $ 4,782   $ 1,524   4,782 1,524  
Supplemental disclosures of cash flow information:              
Cash paid for interest         0 0  
Income taxes paid         0 0  
Operating right-of-use assets and associated liabilities         1,608 0  
ASU 2016-02              
Supplemental disclosures of cash flow information:              
Impact to retained earnings from adoption of ASC Topic 842   $ 230     $ 230 $ 0